StockWatch
·

IFGL Refractories Ltd

BSE: 540774

P/L Snapshot

Q1 FY27 · standalone

vs Q3 FY26·vs Q1 FY26
Revenue
298.72
+9.7%+7.4%
Expenditure
277.70
+2.0%+7.3%
Net Profit
15.78
+543.3%+7.1%
OPM %
9.85%
+5.65pp-2.82pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-39.8353.87147.58241.29334.99Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27
Price Chart
Reports

International Strength Masks Domestic Slowdown; Margins Stay Pinched

refractories · margin compression · international turnaround

Result verdictFollow-upQ1 FY2717 Aug 20266 minIndustrials & Infra

Margin pinch amid solid international; domestic slipping

margin compression · cost inflation · US growth

TranscriptDeep diveQ1 FY2717 Aug 20266 minIndustrials & Infra

IFGL Refractories consolidated PAT jumps 58% YoY, revenue +13%, on US profit turnaround

refractories manufacturing · us profitability recovery · raw material inflation

ResultsQ1 FY2708 Aug 20263 minIndustrials & Infra
Latest
Board Meeting8 Aug, 3:40 pm

IFGL Refractories consolidated PAT jumps 58% YoY, revenue +13%, on US profit turnaround

IFGL Refractories' consolidated (primary) Q1 FY27 (quarter ended June 30, 2026) revenue rose 12.9% YoY to ₹512.4 Cr (₹454.0 Cr in Q1 FY26; +6.1% QoQ from ₹483.0 Cr), while PAT jumped 57.8% YoY to ₹17.06 Cr (₹10.81 Cr a year ago; +19.5% QoQ from ₹14.28 Cr), taking EPS to ₹2.37 from ₹1.50. Neither this quarter nor the year-ago quarter carried exceptional items, so the growth is entirely underlying with no one-off adjustment needed. Standalone (India-only) PAT grew a much softer 7.1% YoY to ₹15.78 Cr on revenue of ₹296.6 Cr — the wide gap versus consolidated confirms the growth is coming almost entirely from overseas operations rather than the domestic book. Net margin expanded to 3.33% from 2.37% a year ago, helped by a lower effective tax rate (26.3% vs 28.75% in Q1 FY26). But operating profitability actually compressed: EBITDA margin fell to roughly 7.2% from ~7.9% both YoY and QoQ, driven by raw material costs rising to 52.6% of revenue from 47.1% in Q1 FY26 (+5.6pp), partly offset by a lighter trading mix (purchase of stock-in-trade fell to 1.3% of revenue from 5.6%). Segment data shows exactly where the growth came from: America segment profit (before finance costs/tax) more than doubled to ₹10.84 Cr from ₹6.04 Cr (+79.5% YoY) on revenue up 32.4% to ₹102.2 Cr, and Europe's loss narrowed 18% to ₹7.09 Cr from ₹8.69 Cr — both directly matching management's Q4 FY26 commentary on 'improving profitability' and 'signs of recovery' internationally, particularly the US. India, the segment management flagged as the primary growth driver, grew revenue only 7.4% YoY to ₹292.9 Cr with segment PBT roughly flat (₹23.24 Cr vs ₹23.45 Cr) — domestic growth undershot the 'double-digit' framing even as consolidated topline cleared it on the strength of international ops. Against management's own FY27 guidance — double-digit growth led by a strong domestic business, with international recovery (especially the US) as a secondary tailwind — this quarter effectively inverts that script: the double-digit consolidated growth (12.9%) and PAT beat were delivered by the overseas turnaround rather than domestic strength, so it is a beat on substance but not on the stated mix. No formal analyst consensus for this quarter could be found (thin sell-side coverage typical of this market cap), so vs-street is unknown; no separate management press release was available beyond the regulatory filing. Alongside results, the board approved a 21.5% final dividend (₹2.15/share) and the AGM was held August 5; subsequent-to-quarter developments include incorporation of a wholly-owned Saudi subsidiary (July 11) and completion of the Czech subsidiary's voluntary liquidation (July 1) — portfolio-shaping moves, not in-quarter financial drivers. Separately, the proposed Marvels JV application for the Bhachau, Gujarat site was closed by the relevant government authority over location concerns, requiring a fresh application with an alternative site — a minor delay to a growth project, not a financial hit this quarter.

8 Aug 2026, 03:40 pm

Corporate Events

Board MeetingIFGLEXPOR
2026
5Aug

Board Meeting

The 19th Annual General Meeting (AGM) of the Members of IFGL…

BSE Filing ↗
DividendIFGLEXPOR
2026
29Jul

₹2.15 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2026
30May

Board Meeting

The board meeting is scheduled to consider and approve audit…

BSE Filing ↗
DividendIFGLEXPOR
2025
6Jun

₹6 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2025
8Feb

Board Meeting

consider and approve unaudited financial results, both on st…

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
9Nov

Board Meeting

Considering and approving unaudited financial results, both …

BSE Filing ↗
DividendIFGLEXPOR
2024
18May

₹7 / share

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
18May

Board Meeting

Consider and approve audited financial results, both on stan…

BSE Filing ↗
Board MeetingIFGLEXPOR
2024
3Feb

Board Meeting

consider and approve unaudited financial results

BSE Filing ↗
Board MeetingIFGLEXPOR
2023
4Nov

Board Meeting

consider and approve unaudited financial results

BSE Filing ↗
DividendIFGLEXPOR
2023
18Aug

₹7 / share

BSE Filing ↗